Skip to main navigation

Life sciences: Driving innovation in a time of change - Ernst & Young - United States

  • Share

Life sciences: the pulse of innovation

Opportunities for growth in life sciences come from Pharma 3.0, health issues facing an increasingly aging global population and a recent push for health care reform. Our knowledge can help position your company as a leader in these diverse and changing markets. Are you ready to grow?

Our global reach

Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential, whether you work in the area of biotechnology, pharmacology or medical technology.

Improving execution

We bring together a worldwide team with deep technical experience in providing assurance, tax, transaction and advisory services to the industry’s leaders.

Biotechnology

Biotechnology

Biotech companies are delivering new levels of health, prosperity and sustainability across the world.

Pharmaceutical

Pharmaceutical

Key drivers are reshaping the pharmaceutical marketplace, including the growing power of healthcare payers, providers and evolving customer needs.

Medical Technology

Medical technology

Fundamental drivers in the global healthcare economy suggest demand for medical technology products should be robust for years to come.

Life Sciences

Contacts

Register now!

Disruptors: Revolutionizing Drug/Dx Reimbursement

11-12 March 2013
Philadelphia, PA

Join us at this premier event which brings together senior executives from leading product (pharma, medtech, biotech) companies along with payers, providers and policymakers to discuss the key issues that will set the product reimbursement agenda over the next few years.

 

Pulse: medical technology report 2012
finger pointing at digital chart
New technologies are blurring the lines between medical devices, diagnostics and health IT, with the potential to revolutionize health care. Will your company be ready? 

Couple061912
Beyond borders: global biotech report 2012
As serious resource constraints continue to plague the industry, how can biotech innovation be sustained? Delve into our 26th edition for key findings and insights.

Back to top